How AI Is Transforming Drug Discovery and Next-Generation Medicine Design

MIT Technology Review profiles the current state of AI-assisted drug discovery, detailing how machine learning models are being used by scientists to design novel therapeutics at a pace and scale previously impossible with traditional methods. The piece covers specific applications including protein structure prediction, generative molecular design, and AI-guided clinical trial optimization. For developers working in biotech or health tech, this provides a useful landscape overview of which AI techniques are seeing real-world adoption in research pipelines versus which remain experimental. It also signals significant enterprise opportunity for teams building AI tooling targeted at pharmaceutical or genomics workflows. The piece is grounded in actual research deployments rather than speculative futures.